BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
水曜日, 9 23

Alnylam Pharmaceuticals Inc

ALNYNASDAQ
Trade with Public
Trade with Public
$251.65
7.333%
近くで: Sep 22, 5:00 PM EST
$252.11
0.460.18%
時間外: 6:05 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Alnylam Pharmaceuticals Financials

Alnylam Pharmaceuticals (ALNY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Alnylam cut its 2026 sales outlook despite a Q2 earnings beat as slower ATTR-CM market growth weighed on expectations and investors reacted.
Vandana Singh

PRO
Alnylam Pharmaceuticals Lowers FY2026 Sales Guidance from $5.300B-$5.800B to $5.275B-$5.725B vs $5.580B Est

Alnylam Pharmaceuticals (NASDAQ:ALNY) lowers FY2026 sales outlook from $5.300 billion-$5.800 billion to $5.275 billion-$5.725 billion vs $5.580 billion estimate.
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Q2 Adj. EPS $1.84 Beats $1.55 Estimate, Sales $1.291B Miss $1.323B Estimate

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings of $1.84 per share which beat the analyst consensus estimate of $1.55 by 18.71 percent. This is a 475 percent increase over earnings of $0.32 per share
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Affirms FY2026 Sales Guidance of $5.300B-$5.800B vs $5.545B Est

Alnylam Pharmaceuticals (NASDAQ:ALNY) affirms FY2026 sales outlook from $5.300 billion-$5.800 billion to $5.300 billion-$5.800 billion vs $5.545 billion estimate.
Benzinga Newsdesk

PRO
Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Beats $0.93 Estimate, Sales $1.167B Beat $1.114B Estimate

Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $0.93 by 113.98 percent. This is a 586.21 percent increase over earnings of $0.29 per
Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved